VistaPath & Gestalt: Joining Forces to Create New AI Capabilities in the Pathology Lab CAMBRIDGE, Mass., July 28, 2022 /PRNewswire/ -- VistaPath, the leading provider of artificial intelligence (AI)-based, data-driven pathology...

CAMBRIDGE, Mass., July 14, 2022 /PRNewswire/ -- VistaPath, the leading provider of artificial intelligence (AI)-based, data-driven pathology processing platforms, today announced that VistaPath Sentinel was validated in a clinical setting...

CAMBRIDGE, Mass., June 30, 2022 /PRNewswire/ -- VistaPath, the leading provider of artificial intelligence (AI)-based, data-driven pathology processing platforms, today announced that it has secured $4 million in seed funding led by...